Understanding cannabinoid psychoactivity with mouse genetic models.
Mackie
Ken
K
Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States of America. kmackie@indiana.edu
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D063385:Cannabinoid Receptor Modulators / Q000502:physiology; D002186:Cannabinoids / Q000633:toxicity*; D004195:Disease Models, Animal; D015870:Gene Expression; D020868:Gene Silencing; D020022:Genetic Predisposition to Disease; D006624:Hippocampus / Q000378:metabolism; D013287:Illicit Drugs / Q000633:toxicity; D051379:Mice; D018345:Mice, Knockout; D008957:Models, Genetic; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000235:genetics* / Q000378:metabolism; D011619:Psychotropic Drugs / Q000633:toxicity*; D043884:Receptor, Cannabinoid, CB1 / Q000235:genetics / Q000378:metabolism
D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D013287:Illicit Drugs; D011619:Psychotropic Drugs; D043884:Receptor, Cannabinoid, CB1